A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Author(s) -
Zhao Chen,
Katherine Cheng,
Zandra E. Walton,
Yuchuan Wang,
Hiromichi Ebi,
Takeshi Shimamura,
Yan Liu,
Tanya Tupper,
Jing Ouyang,
Jie Li,
Peng Gao,
Michele S. Woo,
Chunxiao Xu,
Masahiko Yanagita,
Abigail Altabef,
Shumei Wang,
Charles Lee,
Yuji Nakada,
Christopher G. Peña,
Yanping Sun,
Yoko Franchetti,
Catherine Yao,
Amy Saur,
Michael D. Cameron,
Mizuki Nishino,
D. Neil Hayes,
Matthew D. Wilkerson,
Patrick J. Roberts,
Carrie B. Lee,
Nabeel Bardeesy,
Mohit Butaney,
Lucian R. Chirieac,
Daniel Benevides da Costa,
David M. Jackman,
Norman E. Sharpless,
Diego H. Castrillón,
George D. Demetri,
Pasi A. Jänne,
Pier Paolo Pandolfi,
Lewis C. Cantley,
Andrew L. Kung,
Jeffrey A. Engelman,
KwokKin Wong
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d9z4-0943
Subject(s) - lung cancer , clinical trial , medicine , cancer , oncology , complete response , biology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom